Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

PALMERI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 130.727
NA - Nord America 5.905
AS - Asia 2.592
SA - Sud America 383
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 75
OC - Oceania 5
Totale 139.770
Salva come PNG Salva come JPEG
Nazione #
IE - Irlanda 127.732
US - Stati Uniti d'America 5.802
SG - Singapore 875
CN - Cina 692
RU - Federazione Russa 636
IT - Italia 518
UA - Ucraina 505
DE - Germania 367
HK - Hong Kong 284
FI - Finlandia 282
BR - Brasile 280
VN - Vietnam 217
GB - Regno Unito 168
PL - Polonia 155
JP - Giappone 139
FR - Francia 120
BD - Bangladesh 85
SE - Svezia 84
IN - India 62
KR - Corea 59
CA - Canada 45
CI - Costa d'Avorio 32
NL - Olanda 32
RO - Romania 31
BE - Belgio 29
TR - Turchia 27
AR - Argentina 24
MX - Messico 24
IQ - Iraq 23
CO - Colombia 22
ID - Indonesia 21
ES - Italia 17
AT - Austria 15
ZA - Sudafrica 15
EC - Ecuador 13
VE - Venezuela 13
PK - Pakistan 11
UZ - Uzbekistan 11
JM - Giamaica 10
MY - Malesia 10
CL - Cile 9
PH - Filippine 9
PY - Paraguay 9
EU - Europa 8
KE - Kenya 8
NP - Nepal 8
SA - Arabia Saudita 8
CH - Svizzera 7
CR - Costa Rica 7
EG - Egitto 7
MA - Marocco 7
PE - Perù 6
TH - Thailandia 6
AU - Australia 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
GR - Grecia 5
IR - Iran 5
JO - Giordania 5
NI - Nicaragua 5
UY - Uruguay 5
AL - Albania 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
IL - Israele 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
ET - Etiopia 3
LB - Libano 3
NG - Nigeria 3
PS - Palestinian Territory 3
QA - Qatar 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
PR - Porto Rico 2
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
GA - Gabon 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MM - Myanmar 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
Totale 139.703
Salva come PNG Salva come JPEG
Città #
Dublin 127.731
Ashburn 732
Singapore 604
San Jose 453
Fairfield 397
Chandler 346
Jacksonville 285
Hong Kong 270
Woodbridge 253
Houston 227
Wilmington 207
Ann Arbor 181
Des Moines 154
Seattle 154
Zgierz 141
Tokyo 139
Cambridge 135
Council Bluffs 131
Frankfurt am Main 129
Beijing 127
Moscow 124
Santa Clara 108
Medford 105
Nanjing 91
Altamura 81
Princeton 73
Los Angeles 72
Tulsa 65
Boardman 63
Palermo 62
Ho Chi Minh City 61
Lauterbourg 60
Hanoi 52
Dearborn 49
Hefei 49
Lawrence 49
Dallas 47
New York 47
The Dalles 45
San Diego 37
Chicago 35
Buffalo 33
Abidjan 32
Brussels 29
Shenyang 29
Seongnam 27
Helsinki 26
Nanchang 26
Changsha 24
Milan 24
São Paulo 24
Hebei 22
Ludwigshafen am Rhein 22
Columbus 20
Brooklyn 19
Jinan 18
Amsterdam 17
Rome 17
Tianjin 17
Verona 17
Guangzhou 16
Da Nang 15
City of London 14
Phoenix 14
London 13
Atlanta 12
San Mateo 12
Washington 12
Zhengzhou 12
Cardiff 11
Chennai 11
Nuremberg 11
Jiaxing 10
Kunming 10
Montreal 10
Toronto 10
Belo Horizonte 9
Dhaka 9
Falls Church 9
Johannesburg 9
Ningbo 9
Rio de Janeiro 9
San Paolo di Civitate 9
Tashkent 9
Warsaw 9
Brasília 8
Denver 8
Kingston 8
Kumar 8
Nairobi 8
Taiyuan 8
Auburn Hills 7
Haiphong 7
Istanbul 7
Kilburn 7
Miami 7
Norwalk 7
Orem 7
Ankara 6
Baghdad 6
Totale 134.997
Salva come PNG Salva come JPEG
Nome #
Analisi della frequenza del polimorfismo 1249-1250insACAA del gene TGF-beta2 in un gruppo di pazienti affette da carcinoma della mammella. 127.926
“Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma” 291
“Weekly docetaxel and gemcitabine as first line treatment for metastatic breast cancer: results of a multicenter phase II study” 261
“Cytokine gene polymorphisms and breast cancer susceptibility” 258
“Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5- fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer” 243
“A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer” 243
Prognostic value of vascular endothelial growth factor (VEGF) and D-Dimer (DD) levels in cancer patients 232
"Weekly docetaxel in the treatment of metastatic breast cancer" 230
“Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site” 229
“High efficacy of the CHOP + Rituximab association in a case of primary rectal non Hodgkin lymphoma (NHL)” 227
"Should cirrhosis change our attitude towards treating non-hepatic cancer?" 216
F3 the advantage of ultrasound-guided FNA of pleura in the diagnosis of the malignant pleural effusion 213
"Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet" 212
“Safety and Efficacy of Irinotecan plus High-Dose Leucovorin and Intravenous Bolus 5-Fluorouracil for Metastatic Colorectal Cancer: Pooled Analysis of Two Consecutive Southern Italy Cooperative Oncology Group Trials” 211
“Analysis of interleukin 10 (IL-10)-1082 G/A single nucleotide polymorphism (SNP) genotypes in breast cancer (BC) patients (pts) and in >95 years old cancer free women" 209
“Serum HER-2/neu (s-HER2) levels evaluation in breast cancer (BC) patients (PTS)” 205
Weekly docetaxel (wDOC) for the treatment of metastatic breast cancer (MBC): A literature based meta-analysis 205
Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience 201
“Progression-free survival as an end-point in clinical trials of biotherapeutic agents” 200
“Weekly regimen of cisplatin, epirubicin, 5-Fluorouracil and folinic acid with G-CSF is active in advanced gastroesophageal (GE) and gastric (G) cancer: a phase II study” 199
“Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer:the IGCS-COL multicentre, randomised, phase III study” 196
GASTRIC CANCER (GC) ADJUVANT (A) CHEMOTHERAPY (CT): A LITERATURE BASED META-ANALYSIS (MA) 196
”Biweekly oxaliplatin combined with ral Capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients. A Southern Italy Cooperative Oncology Group phase II study” 196
“Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with metastatic (M) breast cancer (BC): results of an observational study” 195
Investigator-initiated trials of targeted oncology agents: why independent research is at risk? 194
“Clinical surrogate end-points” 192
“Analysis of serum HER-2/neu levels (S-HER2) in breast cancer (BC) patients (pts)” 189
"Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with early (E) breast cancer (BC)” 188
Incidence of different KRAS mutation in non-small cell lung cancer (NSCLC) patients, TAILOR STUDY 185
“Long-Term Outcomes in Stage IIIB Breast Cancer Patients Who Achieved Less Than a Pathological Complete Response ( 184
“Results of a phase II study of a weekly regimen of cisplatin (CDDP),epirubicin (EPI), fluorouracil (5FU) and folinic acid (FA) with G-CSF in gastroesophageal (GE) and gastric (G) cancer” 183
“Dose-Dense Primary Chemotherapy, as Part of Multidisciplinary Treatment, for Inoperable Stage III B Breast Cancer - Long-Term Results of a Phase II Trial” 180
“Oxaliplatin plus high dose folinic acid and 5-fluoruracil i.v. bolus (OXAFAFU) versus irinotecan plus high dose folinic acid and 5-fluoruracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: Southern Italy Cooperative Oncology Group trial 0103” 176
"Weekly regimen of cisplatin (CDDP),epirubicin (EPI), fluorouracil (5FU) and folinic acid (FA) with G-CSF is active in advanced gastroesophageal (GE) and gastric (G) cancer: results of a phase II study” 176
“Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: A multicenter phase II trial of the Southern Italy Cooperative Oncology Group”. 174
“Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium” 165
The effectiveness of the topical use of 0,2% glyceryl trinitrate to decrease post –hemorrhoidectomy pain and to improve wounds healing. 163
“Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401”. 157
“Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey” 157
“Final results of a phase II trial of a weekly (W) poly-chemotherapy (CT) with cisplatin (CDDP), epirubicin (EPI), fluorouracil (5FU), folinic acid (FA) and G-CSF for the treatment of gastroesophageal (GE) and gastric (G) cancer (C)” 152
“Bevacizumab (Bev) with irinotecan (IRI), folinic acid (FA), and 5-fluorouracil (FU) i.v. every 2 weeks (BIFF regimen) as first-line treatment for metastatic colorectal cancer (MCRC) patients (pts): an observational study of the Southern Italy Cooperative Oncology Group (SICOG)” 152
L’anemia nel paziente oncologico 149
“Breast conservation therapy as a safe and effective alternative to mastectomy for selected T4 patients treated with primary chemotherapy as part of multimodality approach” 147
“Biweekly oxaliplatin plus capecitabine (OXXEL) versus oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus (OXAFAFU) in metastatic colorectal carcinoma (MCC): safety interim analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial” 142
“Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small cell lung cancer: a phase III randomized trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)” 142
“Role of loco-regional treatments for patients with breast cancer liver metastases” 140
“Bevacizumab (Bev), irinotecan (IRI), folinic acid (FA), and 5-fluorouracil (FU) every 2 weeks (BIFF regimen) as first-line treatment for metastatic colorectal cancer (MCRC) patients (pts): The SICOG experience” 140
“Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer. A retrospective analysis of the Southern Italy Cooperative Oncology Group trials”. 135
“Carcinoma mammario metastatico: quali farmaci in seconda linea?” 134
"Unknown primary tumors" 134
“Cisplatin (P)- including triplets versus P-free doublets in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC): SICOG 0101 randomized trial” 133
“Unexpectedly high survival rate in very poor prognosis stage III B breast cancer patients receiving cisplatin-based primary chemotherapy. A multicenter Italian study” 133
“Bevacizumab (BEV),irinotecan (IRI), folinic acid (FA) and fluorouracil (FU) every 2 weeks (BIFF regimen) as first-line treatment for metastatic colorectal cancer (MCRC) patients (pts): the Southern Italy Cooperative Oncology Group (SICOG) experience” 133
“The European Medicines Agency (EMEA) guideline on oncology drug development” 132
“OXXEL (oxaliplatin plus Xeloda) vs OXAFAFU (oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus) every 2 weeks in metastatic colorectal carcinoma (MCC): preliminary safety and activity analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial” 131
“Capecitabine or folinic acid/fluorouracil i.v bolus plus eloxatin evaluation (COFFE trial) in metastatic colorectal carcinoma (MCRC): final results of the Southern Italy Cooperative Oncology Group (SICOG) 0401” 129
“OXXEL (Oxaliplatin plus Xeloda) versus OXAFAFU (Oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus) every 2 weeks in metastatic colorectal carcinoma (MCC): preliminary safety and activity analysis” 129
“Randomized comparison of capecitabine versus fluorouracil/leucovorin in combination with oxaliplatin in metastatic colorectal cancer patients: Southern Italy Cooperative Oncology Group trial 0401” 127
“Erlotinib” 126
“Impact of pathological response on survival in stage IIIB T4 LABC patients:long-term outcome of an Italian multicentric study” 126
“Long-term effect in outcomes of intensified primary chemotherapy in poor prognosis LABC T4 patients: results of a multicenter Italian study” 124
“Role of biomarkers in the regulatory process” 123
“Intensified primary chemotherapy improved the outcome in poorer prognosis LABC T4 patients: results of a multicentric Italian study” 120
“Dose-dense chemotherapy and the onset of anemia: new insights” 120
“Biweekly docetaxel (T) and gemcitabine (G) followed by oral vinorelbine as first line treatment of metastatic breast cancer: preliminary results” 118
“Weekly docetaxel (DOC) and Gemcitabine (GEM) as first line treatment for metastatic breast cancer (MBC): results of a multicenter phase II study” 117
“Cisplatin (P)-including triplets versus P-free doublets in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC): final results of the SICOG 0101 randomized trial” 115
”L’associazione di gemcitabina e docetaxel nel trattamento del carcinoma mammario metastatico” 115
“Preliminary results of G > GVIELC: a phase III trial of gemcitabine associated to vindesine or gemcitabine alone in elderly or poor performance patients with advanced non-small cell lung cancer (NSCLC)” 111
“I tumori di origine sconosciuta” 99
“Il rapporto medico-paziente in Oncologia Medica”All Oncology 85
Totale 139.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.247
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022468 0 0 5 15 27 26 26 35 90 86 22 136
2022/20231.066 122 200 12 92 134 160 117 74 93 7 38 17
2023/2024478 29 74 18 87 36 68 44 74 4 6 3 35
2024/20251.132 17 65 96 121 15 41 67 69 82 110 159 290
2025/20264.134 254 113 200 252 365 564 527 396 444 724 126 169
2026/2027910 152 155 603 0 0 0 0 0 0 0 0 0
Totale 139.770